|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
FY2021
12 months to Oct 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation, amortization and impairment | |||||
| Stock-based compensation expense | |||||
| Restructuring and other charges | |||||
| Deferred taxes on earnings | |||||
| Defined benefit plan settlement gains | |||||
| Other, net | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Accounts payable | |||||
| Net investment in leases related to integrated financing | |||||
| Taxes on earnings | |||||
| Restructuring and other | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Investment in property, plant, equipment and purchased intangibles, net | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Purchases of available-for-sale securities and other investments | |||||
| Maturities and sales of available-for-sale securities and other investments | |||||
| Collateral posted for derivative instruments | |||||
| Payments made in connection with business acquisitions, net of cash acquired | |||||
| Proceeds from business divestitures | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Payments of short-term borrowings with original maturities less than 90 days, net | |||||
| Proceeds from debt, net of issuance costs | |||||
| Payment of debt and other associated costs | |||||
| Stock-based award activities and others | |||||
| Repurchase of common stock | |||||
| Cash dividends paid | |||||
| Collateral returned for derivative instruments | |||||
| Collateral (returned) withdrawn for derivative instruments | |||||
| Settlement of cash flow hedges | |||||
| Net cash used in financing activities | |||||
| Increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at end of period (1) | |||||
| Supplemental cash flow disclosures: | |||||
| Income taxes paid, net of refunds | |||||
| Interest expense paid | |||||
Loading...